Clene (NASDAQ: CLNN) to Present at Emerging Growth Conference on July 18, 2024
Clene (NASDAQ: CLNN) and its subsidiary to participate in Emerging Growth Conference, presenting corporate update and discussing investigational therapy CNM-Au8(R)
This news matters because it provides insight into Clene's participation in the Emerging Growth Conference, allowing investors to learn about the company's progress and its investigational therapy for neurodegenerative diseases.
